Skip to main content
. 2015 Jun 4;91(7):520–527. doi: 10.1136/sextrans-2014-051907

Table 2.

Crude and multivariate logistic regression models for factors associated with access to HIV care and ARVs during pregnancy (n=756 pregnancies)

Enrolled in HIV care Accessed ARV drugs
Factor Category OR 95% CI p (LRT) aOR 95% CI p (LRT) OR 95% CI p (LRT) aOR 95% CI p (LRT)
Age* 1.2 1.1 to 1.3 <0.001 1.1* 1.0 to 1.2 0.04 1.1 1.1 to 1.2 <0.001 1.1 1.0 to 1.2 0.05
Year of pregnancy 2005–2006 1 <0.001 1 <0.001 1 <0.001 1   <0.001
2007–2008 26.8 2.8 to 260 14 1.8 to 109 7.1 1.1 to 48 4.2 0.7 to 27
2009–2010 1753 75 to >5000 481 35 to >5000 415 5.1 to 325 21 3.0 to 142
2011–2012 7109 208 to >5000 1051 65 to >5000 207 21 to 2056 72 9.6 to 550
Residence area Rural 1 0.02 1 0.08 1 0.9
Roadside 2.5 1.3 to 4.8 3.4 1.0 to 11 1.0 0.5 to 2.0
Trading Centre 1.6 0.8 to 3.2 2.8 0.8 to 9.8 0.9 0.4 to 1.9
Marital status Married now 1 0.09 1 0.03 1 0.1 1 0.1
Never married 0.3 0.1 to 1.0 0.2 0.0 to 1.1 0.3 0.1 to 1.1 0.2 0.0 to 1.3
Married before 0.8 0.4 to 1.5 0.3 0.1 to 1.0 1.0 0.5 to 1.9 0.7 0.3 to 1.6
Education At least P5 1 0.2 1 0.7
P1–4 0.4 0.2 to 1.2 0.7 0.3 to 1.9
no education 1.0 0.6 to 1.9 0.8 0.4 to 1.5
Religion Catholic 1 0.6 1 0.4
Other Christian 0.8 0.4 to 1.4 0.8 0.5 to 1.5
Muslim 1.5 0.3 to 7.1 2.6 0.6 to 11
Traditional 0.5 0.1 to 2.6 1.6 0.4 to 6.5
Ethnicity Sukuma 1 0.7 1 0.7
Other 0.8 0.3 to 2.2 0.8 0.3 to 2.2
Personal income Farming/manual 1 0.7 1 0.6
income Some business 1.0 0.5 to 1.9 1.1 0.6 to 2.2
None 1.4 0.6 to 3.0 0.7 0.3 to 1.7
Gravidity (pregnancy number) 1 1 <0.001 1 <0.001
2 2.4 0.7 to 8.0 1.7 0.4 to 6.7
3 2.3 0.7 to 8.1 1.7 0.4 to 7.0
4 9.9 2.4 to 40 3.8 0.9 to 15
≥5 21.2 4.6 to 99 7.7 1.9 to 31
Any children died No 1 0.3 1 0.1
died Yes 1.4 0.8 to 2.3 1.6 0.9 to 2.8
Duration of HIV infection ≤2 years 1 <0.001 1 0.002 1 <0.001 1 0.002
>2–4 years 3.3 1.4 to 7.6 1.7 0.6 to 5.0 1.1 0.4 to 2.8 0.7 0.2 to 2.3
>4 years 20.7 6.9 to 61 7.4 2.1 to 25 6.4 2.7 to 15 3.7 1.2 to 11
Prior VCT No 1 <0.001 1 0.09 1 <0.001 1 0.02
Yes 6.7 3.5 to 13 2.2 0.9 to 5.8 5.4 2.8 to 11 2.5 1.1 to 5.8
Knowledge of HIV transmission None 1 <0.001 1 0.02
MTCT 5.3 1.2 to 24 5.8 1.2 to 29
Other modes 6.5 2.2 to 19 3.5 1.1 to 11
No prior report† 2.6 1.0 to 7.3 1.7 0.6 to 5.1
ART knowledge‡ ≤2 correct 1 <0.001 1 <0.001
3 correct 0.9 0.3 to 2.5 1.1 0.3 to 3.3
4–5 correct 4.5 1.6 to 13 5.3 1.8 to 16
No prior report† 0.2 0.1 to 0.4 0.4 0.2 to 0.9
Relatives with/died from HIV No 1 0.1 1 0.02
Yes 1.5 0.9 to 2.7 2.0 1.1 to 3.6
Know someone taking ART No 1 0.01 1 0.02
Yes 2.1 1.2 to 3.8 2.0 1.1 to 3.7
Partner HIV status Unknown § 1 <0.001 1 0.02
Positive 0.2 0.0 to 0.6 0.3 0.1 to 1.4
Negative 0.1 0.0 to 0.4 0.3 0.1 to 1.1
No spousal link 0.4 0.2 to 0.8 0.5 0.2 to 0.9

*Age modelled as a continuous variable, no evidence for departure from linearity (p=0.4 LRT).

†No prior report: knowledge data point after pregnancy, or from an earlier serosurvey questionnaire lacking the same question.

‡Statements: “Drugs can only slow down HIV illness not stop it”; “ART drugs are very dangerous and can kill people”; “ART drugs have to be used for life”; “ART drugs are available free of charge in Tanzania”; “Everyone who is infected with HIV needs drugs”.

§Unknown to the study investigators.

ART, antiretroviral treatment; ARV, antiretroviral; OR, OR (crude); aOR, adjusted OR; LRT, likelihood ratio test; MTCT, mother-to-child transmission; P1–5, primary level; VCT, voluntary counselling and testing.